Leukotrienes and 12-HETE: Key mediators of angiotensin II-mediated vascular effects. Role in hypertension;Leucotriènes et 12-HETE: Modulateurs des effets vasculaires de l'angiotensine II. Implication dans l'hypertension artérielle

Therapie

Volumn 57, Issue 2, 2002, Pages 151-156

  Stanke Labesque, F ^a   Hardy, G ^a   Cracowski, J L ^a   Bessard, G ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

Angiotensin II; Hypertension; Lipoxygenases

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ANGIOTENSIN; LEUKOTRIENE; LIPOXYGENASE INHIBITOR; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE A2;

ARACHIDONIC ACID METABOLISM; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG POTENCY; HUMAN; HYPERTENSION; HYPERTROPHY; MITOGENESIS; PRIORITY JOURNAL; VASCULARIZATION; VASOCONSTRICTION; VASOMOTOR REFLEX;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; CYSTEINE; HUMANS; HYPERTENSION; LEUKOTRIENES; RATS;

EID: 0036319839     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Signal transduction and mechanisms mediating the physiological and pathological actions of angiotensin II in vascular smooth muscle cells
2. Angiotensin II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells
3. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats
4. Thromboxane is required for full expression of angiotensin hypertension in rats
5. Endothelial vasoconstrictor prostanoids modulate contraction to acetylcholine and ANG II in Ren-2 rats
6. Angiotensin II-induced contraction in human internal mammary artery: Effects of cyclooxygenase and lipoxygenase inhibition
7. 5-Lipoxygenase
8. Functional studies of leukotriene receptors in vascular tissues
9. Etude in vitro des effets des cystéinyl leucotriènes sur des préparations vasculaires d'origine humaine
10. Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats
11. Cysteinyl leukotrienes induced P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism
12. Cysteinyl leukotrine D4 induced vascular smooth muscle cell proliferation
13. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes
14. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes
15. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats
16. Cysteinyl leukotrienes mediated enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR
17. Involvement of cysteinyl leukotrienes in angiotensin II-induced contraction in isolated aorta from transgenic (mREN-2)27 rats
18. Increased leukotriene A4 hydrolase expression in the heart of angiotensin II-induced hypertensive rats
19. Eicosanoid regulation of angiogenesis: Role of endothelial arachidonate 12-lipoxygenase
20. A novel form of platelet-type 12-lipoxygenase mRNA n human vascular smooth muscle cells
21. A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for up regulation by angiotensin II
22. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: Its potential role in angiogenesis
23. Role of lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy
24. Endothelium is required for 12-hydroxyeicosatetraenoic acid-induced vasoconstriction
25. 12-Lipoxygenase in porcine coronary microcirculation: Implications for coronary vasoregulation
26. 12-Lipoxygenase products increase monocyte/endothelial interaction
27. Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells
28. A 12(S)-hydroxyeicosatetraenoic acid receptor interacts with steroid receptor coactivator-1
29. 12-Lipoxygenase products modulate calcium signal in vascular smooth muscle cells
30. Mecanism of ANG II-induced mitogenic responses: Role of 12-lipoxygenase and biphasic MAP kinase
31. Effects of a new 12-lipoxygenase inhibitor, daphnodorin A on angiotensin II-induced vascular contraction in hamster
32. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade
33. Effects of a lipoxygenase inhibitor, panaxynol, on vascular contraction induced by angiotensin II
34. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic release and prostanoid synthesis in rabbit aortic smooth muscle cells
35. Prostaglandin I2 contributes to the vasodepressor effect of baicalein in hypertensive rats
36. Eicosanoid regulation of the renal vasculature
37. 12-Hydroxyeicosatetraenoic acid directly potentiates angiotensin II-induced vascular contraction
38. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells
39. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway
40. 12-Hydroxyeicosatetraenoic acid potentiates angiotensin II-induced pressor response in rats
41. Hypotensive effects of the lipoxygenase inhibitor phenidone in two-kidney, one clip goldblatt hypertension
42. Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats
43. The lipoxygenase inhibitor phenidone is a potent hypotensive agent in the spontaneously hypertensive rat
44. Platelet lipoxygenases in spontaneously hypertensive rats
45. Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat
46. Increased levels of 12(S)-HETE in patients with essential hypertension
47. Vascular remodeling in hypertension